Bonnie Ip

Advising Ocean Link Investment Limited on the subscription of 310,407,322 new shares of Comba Telecom Systems Holdings Limited (Stock Code: 2342) (“Comba”) at the subscription price of HK$1.09 per share, with an aggregate subscription amount of HK$338,343,980.98. The subscription of new shares of Comba was completed on 20 March 2025.

Acting for BYD Company Limited on its placement of 129,800,000 new H shares under a general mandate on the Hong Kong Stock Exchange and approximately HK$43,383 million in total was raised. The placement of new H shares under the general mandate was completed on 11 March 2025.

Acting for CRCS (HK) Limited, a wholly-owned subsidiary of China Resources (Holdings) Company Limited, in its acquisition of 60% stake in SWCS International Holding Limited, a leading corporate services provider in Hong Kong, from its shareholders. The consideration of the acquisition amounted to HK$276 million. The transaction completed in January 2024.

Acting for Dah Chong Hong Food International Holdings Limited, a wholly owned subsidiary of Dah Chong Hong Holdings Limited, in relation to its acquisition of 21% stake in Tsit Wing International Holdings Limited (stock code: 2119.hk) from its controlling shareholder. The consideration of the acquisition amounted to HK$133.2 million. The transaction completed and was announced in April 2023.

Advising BYD Company Limited (“BYD”) (SEHK: 1211; SZSE: 002594) from Hong Kong Listing Rules perspective on the proposed spin-off and separate listing of BYD Semiconductor Company Limited on the ChiNext Board of the Shenzhen Stock Exchange.

Acting for Luxshare Precision Limited, a wholly-owned subsidiary of Luxshare Precision Industry Co. Ltd., in relation to its acquisition of the controlling interest in Time Interconnect Technology Limited (“Time Interconnect”) (SEHK: 1729) and its mandatory unconditional cash offer to acquire the entire issued share capital of Time Interconnect as an offeror. The value of the acquisition of the controlling interest amounted to HK$1.1 billion and the mandatory unconditional cash offer involved an amount of HK$480 million. The acquisition was announced in February 2022 and the relevant mandatory unconditional cash offer was completed in April 2022.

Acted for BYD Company Limited (“BYD”) (SEHK: 1211; SZSE:2594) in relation to its placements of H-shares of HK$29,800 million and HK$13,700 million respectively on the Hong Kong Stock Exchange in 2021. The transactions are completed in 2021, and are one of the largest share placements in Hong Kong since 2014.

Acted for Longfor Group Holdings Limited (SEHK: 960) for an investment in Greentown Service Group Co. Ltd. (SEHK: 2869) (“Greentown”) by way of acquisition of shares in issue and subscription of new shares in the share capital of the Greentown. The total consideration for the investment was over HK$2.37 billion

Acted for China Resources Land Limited (SEHK: 1109) to undertake a top-up placing, which involves the placing of existing shares through Goldman Sachs (Asia) L.L.C., the sole placing agent, and top-up subscription of new shares, raising net proceeds of approximately HK$6.72 billion for the Company.

Acting for Vanke Overseas Investment Holding Company Limited (formerly known as Vanke Property (Overseas) Limited) in the acquisition of interest in property interests in Chun Yeung Street, North Point, Hong Kong by way of the acquisition of shares and related shareholder’s loan in the investment holding company that indirectly owns the property interests for redevelopment. The total value of the consideration was approximately HK$600 million. The transaction was completed in June 2019.

Acting for Vanke Overseas Investment Holding Company Limited (formerly known as Vanke Property (Overseas) Limited) in the acquisition of property interests in the United Kingdom and the United States through acquiring equity interests in relevant holding companies, for which constituted a very substantial acquisition under the Hong Kong Listing Rules. The total value of the consideration was approximately RMB 1.1 billion. The transaction was completed in June 2019.

Acted for a pharmaceutical company listed on the Hong Kong Stock Exchange and the Shenzhen Stock Exchange in its disposal of a major subsidiary, which constituted a major transaction of the Company under the Hong Kong Listing Rules, for a total consideration of over RMB 4.5 billion.

Acted for a property developer in its acquisition of a property development company, which constituted a major transaction of the Company under the Hong Kong Listing Rules, for a total consideration of over RMB 3.5 billion.

Acted for companies in Hong Kong and the PRC in their initial public offerings and listings on the Hong Kong Stock Exchange.

Acted for sponsors and underwriters in the initial public offerings and listing of companies in Hong Kong and Singapore on the Main Board and GEM of the Hong Kong Stock Exchange.